Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection

Athymic nude mice recover from an infection with recombinant vaccinia virus (VV) encoding murine interleukin 2 (IL-2), but treatment with a mAb to IL-2 accentuated infection. Administration of a mAb against interferon gamma (IFN-gamma) to mice infected with the IL-2-encoding virus completely prevented the IL-2-induced mechanisms of recovery. Both asialo-GM1+ (NK) and asialo-GM1- (non-NK) cells were participants in the IFN-gamma-mediated recovery of nude mice from infection with the IL-2-encoding VV recombinant. Depletion of asialo-GM1+ cells exacerbated infection, though not as much as anti-IFN-gamma mAb. In vitro, both asialo-GM1+ and asialo-GM1- nude mouse splenocytes produced IFN-gamma in response to IL-2.

[1]  N. King,et al.  Target Cell Lysis by Natural Killer Cells is Influenced by β2‐Microglobulin Expression , 1989, Scandinavian journal of immunology.

[2]  R. Zinkernagel,et al.  Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice , 1989, Journal of virology.

[3]  T. Miyawaki,et al.  Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice. , 1989, Cellular immunology.

[4]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[5]  S. Rosenberg,et al.  Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. , 1988, Journal of immunology.

[6]  B. Moss,et al.  Prevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expression , 1987, Nature.

[7]  B. Coupar,et al.  Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection , 1987, Nature.

[8]  H. Young,et al.  One-signal requirement for interferon-gamma production by human large granular lymphocytes. , 1987, Journal of immunology.

[9]  T. Waldmann,et al.  Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes. , 1987, Journal of immunology.

[10]  B. Coupar,et al.  Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. , 1986, Microbial pathogenesis.

[11]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[12]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[13]  J Stein-Streilein,et al.  In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. , 1986, Journal of immunology.

[14]  E. Schiltknecht,et al.  Influenza Virus‐Specific T Cells Fail to Reduce Lung Virus Titres in Cyclosporin‐Treated, Infected Mice , 1985, Scandinavian journal of immunology.

[15]  J. Lowenthal,et al.  Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells , 1985, Nature.

[16]  R. Welsh,et al.  Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells , 1985, The Journal of experimental medicine.

[17]  T. Braciale,et al.  In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific , 1984, The Journal of experimental medicine.

[18]  W. Farrar,et al.  Interleukin 2 regulates immune interferon (IFN gamma) production by normal and suppressor cell cultures. , 1982, Journal of immunology.

[19]  M. Bevan,et al.  Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen , 1982, The Journal of experimental medicine.

[20]  B. Askonas,et al.  Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell , 1982, Nature.

[21]  W. Farrar,et al.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. , 1981, Journal of immunology.

[22]  T. Braciale,et al.  Role of T-cell function in recovery from murine influenza infection. , 1979, Cellular immunology.

[23]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[24]  R. Zinkernagel,et al.  Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled , 1977, The Journal of experimental medicine.

[25]  R. Zinkernagel,et al.  H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. , 1976, Journal of immunology.

[26]  R. Gallo,et al.  Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.

[27]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.

[28]  J. Rhim,et al.  Non‐producer human cells induced by murine sarcoma virus , 1975, International journal of cancer.

[29]  R. Blanden.  MECHANISMS OF RECOVERY FROM A GENERALIZED VIRAL INFECTION: MOUSEPOX , 1971, The Journal of experimental medicine.

[30]  F. Jensen,et al.  INFECTION OF HUMAN AND SIMIAN TISSUE CULTURES WITH ROUS SARCOMA VIRUS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Decker,et al.  Macrophage precursors as natural killer cells against tumor cells and microorganisms. , 1988, Natural immunity and cell growth regulation.

[32]  G. Wong,et al.  Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.

[33]  W. Stewart,et al.  Potentiation of the Antiviral and Anticellular Activities of Interferons by Mixtures of HuIFN-γ and HuIFN-α or HuIFN-β , 1985 .

[34]  R. Zubler,et al.  B cell growth factor activity of immunoaffinity‐purified and recombinant human interleukin 2 , 1985, European journal of immunology.

[35]  R. Zinkernagel,et al.  15 – Lymphocyte–Macrophage Interactions and Macrophage Activation in the Expression of Antimicrobial Immunity in Vivo , 1976 .